# Transperineal Laser Ablation Treatment (TPLA) for Prostate Cancer (PCa) Registry

> **NCT05163197** · — · RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 200 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** Transperineal Laser Ablation of Prostate Cancer

## Key facts

- **NCT ID:** NCT05163197
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05163197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05163197, "Transperineal Laser Ablation Treatment (TPLA) for Prostate Cancer (PCa) Registry". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05163197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*